Applications of (R)-(-)-2-(Anilinomethyl)Pyrrolidine in Industrial Manufacturing

(R)-(-)-2-(Anilinomethyl)Pyrrolidine serves as a specialized chiral building block in pharmaceutical and fine chemical synthesis, enabling downstream manufacturers to achieve targeted enantiomeric purity. With documented performance in enantioselective catalysis and active pharmaceutical ingredient (API) construction, this intermediate supports several high-value industrial sectors, each with its own strict compliance requirements, processing protocols, and formulation standards.

1. Antidepressant API Synthesis (Chiral Active Intermediate for Paroxetine)

Pharmaceutical companies use (R)-(-)-2-(Anilinomethyl)Pyrrolidine as a critical precursor during the asymmetric synthesis of selective serotonin reuptake inhibitor (SSRI) APIs such as Paroxetine. This chiral amine enables enantioselective transformations required for regulatory pharmaceutical approval. The compound enters the multi-step production route after initial aromatic substitution, directly affecting final API stereochemistry. Typical inclusion levels optimize conversion yield and minimize racemization risk according to batch reactor conditions. The process prioritizes traceability under global regulatory frameworks to ensure finished tablets and capsules meet release specifications.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211 (US FDA cGMP for finished pharmaceuticals)
• European Pharmacopoeia (Ph. Eur.) Monograph 01/2024:2576
• China Pharmacopoeia ChP (2025 Edition) – API Production/Chiral Purity Requirement

Typical usage ratio

• 0.9–1.2 molar equivalents, based on target Paroxetine intermediate batch size; adjustment according to enantiomeric purity and process scale

Downstream process integration

• Charged during the enantioselective addition step post-aryl precursor activation; optimized within temperature-controlled, solvent-free reactors or with green solvents

Final product types

• Paroxetine hydrochloride tablets (various dosages)
• Paroxetine active pharmaceutical ingredient powder (bulk supply)

2. Chiral Ligand Preparation for Asymmetric Catalysis

Fine chemical producers and contract research organizations integrate this compound as a starting material in the synthesis of customized chiral ligands, used in transition-metal catalysis for stereospecific reactions. The compound’s anilinomethyl group offers unique spatial control in ligand frameworks, proven to enhance selectivity in rhodium- or palladium-catalyzed hydrogenation and cross-coupling. Formulators determine batch-specific addition based on the desired ligand backbone and target catalytic activity, with traceability documentation per ISO guidelines. Final ligands achieve high turnover frequency in downstream specialty chemical manufacturing.

Industry compliance standards

• ISO 9001:2015 Quality Management for Specialty Chemicals
• REACH Registration (EC 1907/2006) for intermediates
• Responsible Care® Global Charter – Product Stewardship

Typical usage ratio

• 0.85–1.5 molar equivalents, determined by ligand design and batch protocol in ligand synthesis

Downstream process integration

• Introduced during nucleophilic substitution or metal-coordination steps to assemble novel ligand scaffolds

Final product types

• Custom chiral phosphine ligands
• Pyrrolidine-derived bidentate catalysts
• Enantioselective hydrogenation catalyst complexes

3. Agrochemical Intermediate Production (Chiral Auxiliary Segment)

Agrochemical formulators utilize (R)-(-)-2-(Anilinomethyl)Pyrrolidine in the synthesis of high-value chiral pesticides and herbicides, where optical purity critically influences biological target specificity and environmental safety. Precision feeding into the cyclization and auxiliary installation phases supports downstream processes in industrial-scale pesticide synthesis. The ratio varies with crop-protection molecule requirements, while all operations comply with multi-national regulatory controls on intermediates and final residue profiles.

Industry compliance standards

• FAO/WHO Guidelines on Pesticide Specifications and Quality Control
• US EPA Pesticide Registration Manual Requirements for Intermediates
• ISO 17025 Laboratory Accreditation for Analytical Testing

Typical usage ratio

• 0.6–1.3 molar equivalents; adjusted in real time according to yield monitoring and enantiomeric excess targets

Downstream process integration

• Fed into the coupling or cyclization reaction for chiral pesticide backbone construction, under inert atmospheres to preserve stereochemistry

Final product types

• Enantioselective herbicide intermediates
• Chiral insecticide API stocks

4. Fine Chemical Synthesis for High-Purity Analytical Reference Standards

Specialty laboratories and QC divisions source (R)-(-)-2-(Anilinomethyl)Pyrrolidine for the production of enantiopure analytical standards used in regulatory method validation, impurity profiling, and stability studies. The compound provides a stereochemically-defined backbone during derivatization, supporting products submitted for global cross-laboratory reference. Precise dosing and purity certification are mandated throughout the prep process, with the finished reference compounds batch-certified against metrology standards.

Industry compliance standards

• ISO 17034:2016 (Reference Material Producers Accreditation)
• USP General Chapter <1225> Validation of Compendial Methods
• OECD Good Laboratory Practice (GLP) Principles

Typical usage ratio

• 0.95–1.05 molar equivalents, calculated per synthesized reference material batch to ensure stereochemical identity

Downstream process integration

• Charged during the derivatization or labeling stage to generate analytical standards with traceable chiral configurations

Final product types

• Certified chiral reference compounds
• Stability-indicating impurity markers
• Multi-component system suitability standards